Canaccord analyst George Gianarikas raised the firm’s price target on Enovix to $22 from $20 and keeps a Buy rating on the shares. The firm said they continue to execute on their operational turnaround as it readies its Gen2 line to begin volume production next year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ENVX: